This is a preprint.
Next-generation Serology by Mass Spectrometry: Readout of the SARS-CoV-2 Antibody Repertoire
- PMID: 34268518
- PMCID: PMC8282107
- DOI: 10.1101/2021.07.06.21259226
Next-generation Serology by Mass Spectrometry: Readout of the SARS-CoV-2 Antibody Repertoire
Update in
-
Next-Generation Serology by Mass Spectrometry: Readout of the SARS-CoV-2 Antibody Repertoire.J Proteome Res. 2022 Jan 7;21(1):274-288. doi: 10.1021/acs.jproteome.1c00882. Epub 2021 Dec 8. J Proteome Res. 2022. PMID: 34878788 Free PMC article.
Abstract
Methods of antibody detection are used to assess exposure or immunity to a pathogen. Here, we present Ig-MS , a novel serological readout that captures the immunoglobulin (Ig) repertoire at molecular resolution, including entire variable regions in Ig light and heavy chains. Ig-MS uses recent advances in protein mass spectrometry (MS) for multi-parametric readout of antibodies, with new metrics like Ion Titer (IT) and Degree of Clonality (DoC) capturing the heterogeneity and relative abundance of individual clones without sequencing of B cells. We apply Ig-MS to plasma from subjects with severe & mild COVID-19, using the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 as the bait for antibody capture. Importantly, we report a new data type for human serology, with compatibility to any recombinant antigen to gauge our immune responses to vaccination, pathogens, or autoimmune disorders.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous